Keratin Peptides for Hair and Nails
Structural Protein Peptides
90%
Hair is approximately 90% keratin by dry weight, making it the dominant structural protein in human hair, nails, and the outer layer of skin.
Bragulla and Homberger, Journal of Anatomy, 2009
Bragulla and Homberger, Journal of Anatomy, 2009
View as imageKeratin is the structural protein that gives hair its tensile strength, nails their hardness, and skin its protective outer layer. It is an alpha-helical protein that forms coiled-coil dimers, which assemble into intermediate filaments that provide mechanical resistance. When hair becomes brittle, nails crack, or skin loses its barrier function, the underlying problem is often structural protein degradation. Keratin peptide supplements attempt to address this by providing hydrolyzed keratin fragments that can be absorbed orally and theoretically incorporated into new keratin structures. The pillar article on elastin peptides covers another structural protein in this cluster, and the sibling article on fibronectin and laminin addresses the extracellular matrix scaffolding that supports keratin-producing cells.
Key Takeaways
- Hair is approximately 90% keratin by dry weight; nails are also primarily keratin, organized into hardened, cross-linked sheets
- Keratin peptides are produced by enzymatic or chemical hydrolysis that breaks the intact protein into fragments of 10 to 50 amino acids that can be absorbed through the gastrointestinal tract
- A 2014 randomized controlled trial of Cynatine HNS (500 mg keratin daily for 90 days) reported statistically significant improvements in hair strength and reduced hair loss during washing compared to placebo in 50 women (Beer et al., 2014)
- The total clinical trial evidence consists of a handful of small studies (largest n=50), all funded by supplement manufacturers, with no independent replication
- Collagen peptide supplements have stronger evidence for skin health, with multiple independent RCTs showing improvements in skin hydration and elasticity (Aguirre-Cruz et al., 2020)
- No head-to-head trial has compared keratin peptide supplements against collagen peptide supplements for hair or nail outcomes
What Keratin Actually Is
Keratin belongs to the intermediate filament family of structural proteins. Humans produce two types: type I (acidic) and type II (basic/neutral) keratins that pair together to form heterodimers. These dimers assemble into protofilaments, then protofibrils, and finally into the intermediate filaments that give structural tissues their mechanical properties.
In hair, keratin filaments are embedded in a sulfur-rich matrix of keratin-associated proteins (KAPs). The disulfide bonds between cysteine residues in adjacent keratin chains create the cross-linked network that gives hair its strength and elasticity. A single human hair can support approximately 100 grams of weight before breaking, which is a direct consequence of this keratin architecture.
In nails, the same basic keratin structure is organized into flattened, tightly packed sheets. Nail keratin has higher sulfur content and more disulfide cross-links than hair keratin, which explains why nails are harder but less flexible.
The keratins in hair and nails are "hard" keratins (types Ha1-Ha8 and Hb1-Hb6), distinct from the "soft" keratins found in skin epidermis. This distinction matters for supplementation because hard keratin synthesis requires specific amino acid ratios and post-translational modifications (particularly cysteine cross-linking) that soft keratin does not.
How Keratin Peptides Are Made
Intact keratin protein is insoluble and cannot be absorbed through the GI tract. Supplement manufacturers address this by hydrolyzing keratin into smaller peptide fragments.
The hydrolysis process typically starts with a keratin source, usually sheep's wool (the most common), but sometimes poultry feathers or human hair waste. The raw material is cleaned, sterilized, and then subjected to either enzymatic hydrolysis (using proteases like keratinases) or chemical hydrolysis (using acid or alkaline conditions at elevated temperatures).
The resulting hydrolysate contains a mixture of peptide fragments ranging from 2 to 50 amino acids. The amino acid profile is high in cysteine (the sulfur-containing amino acid critical for disulfide bond formation), glutamic acid, proline, serine, and leucine. This profile differs from collagen hydrolysates, which are dominated by glycine, proline, and hydroxyproline.
The key question is whether these ingested keratin peptide fragments can reach hair follicles and nail matrix cells in meaningful concentrations and be utilized for new keratin synthesis. This has not been directly demonstrated in humans. The theoretical pathway is: oral absorption from the gut, distribution via blood, uptake by hair follicle keratinocytes, and incorporation into new keratin fibers. Each step involves biological barriers and competing metabolic fates.
The Clinical Trial Evidence
The Cynatine HNS Trial
The most cited clinical trial for keratin peptide supplementation was published in 2014 and evaluated Cynatine HNS, a solubilized keratin derived from sheep's wool. The randomized, double-blind, placebo-controlled trial enrolled 50 women who received either 500 mg of Cynatine HNS plus vitamins and minerals or placebo daily for 90 days (Beer et al., 2014, The Scientific World Journal).
The results reported:
- Hair strength increased by 12% in the keratin group versus no change in placebo
- Hair loss during washing decreased by 30%
- Nail hardness improved, with 51% reduction in nail brittleness scores
- No significant adverse effects
These numbers look impressive, but context matters. The trial had only 50 participants (25 per group). It was funded by the manufacturer of Cynatine HNS. The vitamins and minerals included in the active capsules (but not in the placebo) could account for some or all of the observed effects. No independent laboratory has replicated the study.
Feather Keratin Hydrolysate
A 2024 randomized, double-blind, placebo-controlled study tested a novel keratin hydrolysate derived from poultry feathers (FKH) at doses of 500 mg or 1,000 mg daily for 90 days. The study reported improvements in skin appearance, hair, and nail parameters compared to placebo (Tursi et al., 2025, Journal of Cosmetic Dermatology). Like the Cynatine trial, this study was manufacturer-funded and relatively small.
The Evidence-Based Assessment
A 2019 review in the American Journal of Clinical Dermatology examined the evidence for skin, hair, and nail supplements broadly. The authors concluded that while some supplements show promise, the overall evidence quality is low, with most studies being small, short-term, and industry-funded. Keratin supplements specifically were noted to have very limited independent evidence.
How Keratin Compares to Collagen Peptides
Collagen peptide supplements are the most direct comparison for keratin supplements, since both target structural protein support. The evidence base for collagen is substantially larger and more robust.
Aguirre-Cruz et al. (2020) reviewed collagen hydrolysates for skin protection in Antioxidants, covering both oral supplementation and topical formulation studies. They found consistent evidence that oral collagen peptide supplementation (2.5 to 10 g/day) improved skin hydration, elasticity, and wrinkle depth across multiple independent RCTs.[1]
Zague et al. (2018) demonstrated in Cell Biology International that collagen peptides modulated extracellular matrix metabolism by human dermal fibroblasts, providing a mechanistic basis for oral collagen supplementation effects on skin. Collagen peptides stimulated fibroblasts to produce more type I collagen, hyaluronic acid, and elastin.[2]
For hair specifically, the evidence favors a combined approach. Collagen peptides provide amino acids (particularly proline and glycine) that support the dermal layer around hair follicles, while keratin peptides provide cysteine and other amino acids specific to the hair shaft itself. No trial has tested this combination against either alone.
The GHK-Cu Connection: Peptides That Affect Hair Follicles
A different approach to peptide-based hair support involves signaling peptides rather than structural protein supplementation. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a tripeptide that has been studied for its effects on hair follicle biology.
Arul et al. (2005) published research in the Journal of Biomedical Materials Research on biotinylated GHK peptide incorporated into a collagenous matrix for dermal wound healing. While this study focused on wound repair rather than hair growth, it demonstrated that GHK-Cu influences the dermal environment that supports hair follicle function.[3]
The theoretical advantage of GHK-Cu over keratin peptides is mechanism: GHK-Cu activates gene expression pathways that promote tissue remodeling, including upregulating genes involved in hair follicle cycling. Rather than providing raw building materials (as keratin peptides attempt to do), GHK-Cu signals cells to build more actively. For the full research profile on this copper peptide, see the articles on GHK-Cu wound repair and how GHK-Cu declines with age.
Amino Acid Composition: Why Source Matters
Not all keratin peptide products are equivalent. The amino acid composition depends on the source material and the hydrolysis process.
Wool-derived keratin is high in cysteine (approximately 7-20% of amino acid content depending on the wool type and processing), which is the amino acid most critical for disulfide bond formation in hair and nails. Feather-derived keratin has a different amino acid profile with lower cysteine content but higher concentrations of hydrophobic amino acids.
This distinction matters because the theoretical mechanism of keratin peptide supplementation depends on delivering cysteine and other sulfur-containing amino acids to hair follicles. If the supplement is derived from a source with low cysteine content, the theoretical rationale weakens. Most clinical trial products use wool-derived keratin, and the results should not be extrapolated to feather-derived or synthetic alternatives without separate evidence.
For comparison, collagen peptides are glycine-rich (approximately 33% glycine) with high proline and hydroxyproline content but virtually no cysteine. This fundamentally different amino acid profile means collagen and keratin peptides target different aspects of hair and nail biology: collagen supports the surrounding connective tissue, while keratin provides building blocks for the structural fiber itself.
What the Evidence Does Not Support
Several claims commonly made about keratin peptide supplements lack scientific backing:
"Keratin peptides repair damaged hair." Once hair exits the follicle, it is biologically dead tissue. No ingested supplement can repair existing hair strands. Keratin peptide supplements can only theoretically influence new hair growth from the follicle. Topical keratin treatments (applied directly to the hair shaft) work through a different mechanism: physical coating and filling of damaged cuticle, which is a cosmetic rather than biological effect.
"Keratin supplements prevent hair loss." No clinical trial has demonstrated that keratin peptide supplementation prevents androgenetic alopecia (pattern baldness), telogen effluvium (stress-related hair loss), or any diagnosed form of hair loss. The Cynatine trial measured reduced hair shedding during washing, which is different from preventing hair loss conditions.
"You need keratin supplements because your body can't make enough." Healthy adults produce adequate keratin from dietary protein. Keratin is synthesized from amino acids obtained through normal protein digestion. Supplementing with keratin peptides specifically is only theoretically advantageous if the peptide fragments are preferentially directed to keratin-producing cells, which has not been demonstrated.
"Higher doses work better." The dose-response relationship for keratin peptide supplementation has not been established. The 2024 feather keratin trial tested 500 mg versus 1,000 mg but did not report a clear dose-response for hair or nail outcomes.
Limitations and Honest Assessment
The keratin peptide supplement field has three fundamental weaknesses:
Tiny trials. The largest published RCT had 50 participants. In pharmaceutical development, this would be considered a pilot study, not evidence of efficacy. The clinical significance of a 12% increase in hair strength measured by a specific instrument in 25 women is uncertain.
Industry funding. Every published keratin supplement trial has been funded by the supplement manufacturer. This does not automatically invalidate the results, but it creates a systematic bias toward positive findings, particularly when combined with small sample sizes.
No mechanism confirmation. The assumption that ingested keratin peptides reach hair follicles and are utilized for new keratin synthesis has not been confirmed with labeled tracer studies in humans. It is possible that the amino acids are simply metabolized for general protein needs, providing no advantage over eating any other protein source.
For the broader context of structural protein peptide research, the pillar article on elastin peptides covers a structural protein with more mechanistic data, and BPC-157's effect on fibroblasts and collagen synthesis addresses how peptides influence the cells that produce structural proteins.
The Bottom Line
Keratin peptide supplements are marketed for hair and nail strength based on a small number of manufacturer-funded clinical trials. The largest study (50 participants, 90 days) showed improved hair strength and reduced shedding compared to placebo, but the evidence base is too thin and too commercially dependent for strong conclusions. Collagen peptide supplements have substantially more clinical evidence for related skin and connective tissue outcomes. The fundamental question of whether ingested keratin peptides are preferentially utilized by hair follicles remains unanswered.